Sera Prognostics names Scott Gleason as CFO, effective Aug. 31

Sera Prognostics Inc. (Nasdaq: SERA) announced the appointment of Scott Gleason as Chief Financial Officer, effective August 31, 2026, according to a company statement.

Gleason brings more than 25 years of experience in healthcare, diagnostics, and capital markets. He most recently served as Vice President of Investor Relations and Treasury at Neogen Corporation. He previously held CFO roles at LarmorBio and NX Prenatal, served as interim CFO at OraSure Technologies, and led corporate strategy and investor relations at Myriad Genetics. He holds a B.S. in Economics from the United States Air Force Academy.

"Scott brings financial leadership, operating discipline, and capital markets experience that will support Sera's continued growth and execution," said Zhenya Lindgardt, Chief Executive Officer of Sera Prognostics.

Austin Aerts, who has served as CFO since June 2023 and joined the company in 2017, will transition to an advisory role focused on strategic initiatives. Aerts played a role in guiding the company through its initial public offering and its transition to the public markets.

You May Also Be Interested In

• Longeveron names Nirav Jhaveri as CFO
• Baxter names John Rogers as CFO, effective October 2026
• BetterLife Pharma names neurologist as chief medical officer